A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT03656744 · COMPLETED

Trial details

NCT number: NCT03656744
Sponsor: HighTide Biopharma Pty Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fatty Liver, Nonalcoholic NAFLD Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis Digestive System Diseases Type 2 Diabetes Mellitus (T2DM)

Start date: 2018-11-26
Primary completion: 2020-02-07
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.